• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Trogenix: Venture Capital Funding History

Trogenix

To add a bio or update company history, please click update information.

News from Trogenix

    Trogenix raises £70m Series A led by IQ Capital to advance precision cancer therapies into clinical trialsTrogenix raises £70m Series A led by IQ Capital to advance precision cancer therapies into clinical trials
    Trogenix
    6 Oct 2025

    Trogenix raises £70m Series A led by IQ Capital to advance precision cancer therapies into clinical trials

    Trogenix develops precision genetic medicines for aggressive solid tumours, using targeted delivery systems designed to kill cancer cells and stimulate immune responses while limiting damage to healthy tissue.

Trogenix
  • Life Sciences
  • Edinburgh, United Kingdom
  • £70m
  • trogenix.com
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn